The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community

被引：11

作者：

Garibotto, Valentina ^{[1
,2
]}

Albert, Nathalie L. ^{[3
]}

Barthel, Henryk ^{[4
]}

van Berckel, Bart ^{[5
]}

Boellaard, Ronald ^{[5
]}

Brendel, Matthias ^{[3
,6
,7
]}

Cecchin, Diego ^{[8
]}

Ekmekcioglu, Ozgul ^{[9
]}

van de Giessen, Elsmarieke ^{[5
]}

Guedj, Eric ^{[10
]}

Lammerstma, Adriaan A. ^{[5
,11
]}

Semah, Franck ^{[12
]}

Traub-Weidinger, Tatjana ^{[13
]}

Van Weehaeghe, Donatienne ^{[14
]}

Morbelli, Silvia ^{[15
]}

机构：

[1] Univ Hosp Geneva, Diagnost Dept, Nucl Med & Mol Div, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland

[2] Univ Geneva, NIMTLab, Fac Med, Geneva, Switzerland

[3] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Nucl Med, Munich, Germany

[4] Univ Hosp Leipzig, Dept Nucl Med, Leipzig, Germany

[5] Univ Amsterdam, Dept Radiol & Nucl Med, Med Centers, Locat VUMC, Amsterdam, Netherlands

[6] DZNE German Ctr Neurodegenerat Dis, Munich, Germany

[7] Univ Munich, SyNergy, Munich, Germany

[8] Univ Hosp Padua, Dept Med DIMED, Nucl Med Unit, Padua, Italy

[9] Univ Hlth Sci, Sisli Hamidiye Etfal Educ & Res Hosp, Dept Nucl Med, Istanbul, Turkey

[10] Aix Marseille Univ, Cent Marseille, Timone Hosp, APHM,Nucl Med Dept,Inst Fresnel,CNRS,CERIMED, Marseille, France

[11] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Nucl Med & Mol Imaging, Groningen, Netherlands

[12] Univ Lille, CHU, Dept Nucl Med, Lille, France

[13] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, Vienna, Austria

[14] UZ Leuven, Nucl Med, Leuven, Belgium

[15] IRCCS Osped Policlin San Martino, Nucl Med Unit, Genoa, Italy

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 10期

基金：

瑞士国家科学基金会;

关键词：

AMYLOID-PET; BIOMARKERS; DEMENTIA; TRIALS;

D O I：

10.1007/s00259-021-05485-y

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：3033 / 3036

页数：4

共 30 条

[1] Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging [J].

Alves, Isadora Lopes ;

Heeman, Fiona ;

Collij, Lyduine E. ;

Salvado, Gemma ;

Tolboom, Nelleke ;

Vilor-Tejedor, Natalia ;

Markiewicz, Pawel ;

Yaqub, Maqsood ;

Cash, David ;

Mormino, Elizabeth C. ;

Insel, Philip S. ;

Boellaard, Ronald ;

van Berckel, Bart N. M. ;

Lammertsma, Adriaan A. ;

Barkhof, Frederik ;

Domingo Gispert, Juan .

ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)

[2]

[Anonymous], 2024, Draft guidance for IndustryEarly Alzheimer's disease (AD), developing drugs for treatment

[3] The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers [J].

Ashton, N. J. ;

Leuzy, A. ;

Karikari, T. K. ;

Mattsson-Carlgren, N. ;

Dodich, A. ;

Boccardi, M. ;

Corre, J. ;

Drzezga, A. ;

Nordberg, A. ;

Ossenkoppele, R. ;

Zetterberg, H. ;

Blennow, K. ;

Frisoni, G. B. ;

Garibotto, V. ;

Hansson, O. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (07) :2140-2156

[4] Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing [J].

Barthel, Henryk ;

Seibyl, John ;

Lammertsma, Adriaan A. ;

Villemagne, Victor L. ;

Sabri, Osama .

JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (08) :1105-1106

[5] The role of positron emission tomography imaging in understanding Alzheimer's disease [J].

Barthel, Henryk ;

Seibyl, John ;

Sabri, Osama .

EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (04) :395-406

[6] Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements [J].

Broich, Karl ;

Weiergraeber, Marco ;

Hampel, Harald .

PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) :498-500

[7] Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol [J].

Bullich, Santiago ;

Barthel, Henryk ;

Koglin, Norman ;

Becker, Georg A. ;

De Santi, Susan ;

Jovalekic, Aleksandar ;

Stephens, Andrew W. ;

Sabri, Osama .

JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) :1104-1110

[8] Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study [J].

Ceccaldi, Mathieu ;

Jonveaux, Therese ;

Verger, Antoine ;

Krolak-Salmon, Pierre ;

Houzard, Claire ;

Godefroy, Olivier ;

Shields, Trevor ;

Perrotin, Audrey ;

Gismondi, Rossella ;

Bullich, Santiago ;

Jovalekic, Aleksandar ;

Raffa, Nicola ;

Pasquier, Florence ;

Semah, Franck ;

Dubois, Bruno ;

Habert, Marie-Odile ;

Wallon, David ;

Chastan, Mathieu ;

Payoux, Pierre ;

Stephens, Andrew ;

Guedj, Eric .

ALZHEIMERS & DEMENTIA, 2018, 14 (03) :293-305

[9] Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias [J].

Chetelat, Gael ;

Arbizu, Javier ;

Barthel, Henryk ;

Garibotto, Valentina ;

Law, Ian ;

Morbelli, Silvia ;

van de Giessen, Elsmarieke ;

Agosta, Federica ;

Barkhof, Frederik ;

Brooks, David J. ;

Carrillo, Maria C. ;

Dubois, Bruno ;

Fjell, Anders M. ;

Frisoni, Giovanni B. ;

Hansson, Oskar ;

Herholz, Karl ;

Hutton, Brian F. ;

Jack, Clifford R., Jr. ;

Lammertsma, Adriaan A. ;

Landau, Susan M. ;

Minoshima, Satoshi ;

Nobili, Flavio ;

Nordberg, Agneta ;

Ossenkoppele, Rik ;

Oyen, Wim J. G. ;

Perani, Daniela ;

Rabinovici, Gil D. ;

Scheltens, Philip ;

Villemagne, Victor L. ;

Zetterberg, Henrik ;

Drzezga, Alexander .

LANCET NEUROLOGY, 2020, 19 (11) :951-962

[10] Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) [J].

Chincarini, A. ;

Peira, E. ;

Morbelli, S. ;

Pardini, M. ;

Bauckneht, M. ;

Arbizu, J. ;

Castelo-Branco, M. ;

Buesing, K. A. ;

de Mendonca, A. ;

Didici, M. ;

Dottorini, M. ;

Engelborghs, S. ;

Ferrarese, C. ;

Frisoni, G. B. ;

Garibotto, V ;

Guedj, E. ;

Hausner, L. ;

Hugon, J. ;

Verhaeghe, J. ;

Mecocci, P. ;

Musarra, M. ;

Queneau, M. ;

Riverol, M. ;

Santana, I ;

Guerra, U. P. ;

Nobili, F. .

NEUROIMAGE-CLINICAL, 2019, 23

← 1 2 3 →